New JAK City, PE Exit Struggles, CBD for Dogs Inches Forward, PetcoLove 4M

About this episode

This episode covers recent developments in veterinary medicine, including FDA approvals and challenges faced by private equity firms in the industry.

Second week of March, what'd you miss in vet med? FDA approves Merck's NUMELVI — first second-gen JAK inhibitor for dogs PE firms struggling to exit pandemic-era vet deals (Encore, CareVet, and Blue River hit the market) InnoCan gets third FDA fee waiver for CBD pain injection in dogs PetSmart + Healthy Paws expand insurance partnership Petco Love hits 4 million free vaccines Helpful links: The Bird Bath substack VRCE - The Veterinary Profession’s #1 CSR Development Program 2026 Animal Health Summit Emerging Company Application TikTok - Is it Pet Smart or Pets Marks?

People in this episode

Host: The Bird Bath

Topics covered

• veterinary medicine
• FDA approvals
• pet insurance
• CBD for pets
• pandemic impact on vet deals

Keywords

• veterinary medicine
• FDA
• Merck
• CBD for dogs
• pet insurance
• Petco Love
• pandemic

Mentioned in this episode

Organizations: Merck, Encore, CareVet, Blue River, InnoCan, PetSmart, Healthy Paws, Petco Love

Products: NUMELVI, CBD pain injection

More episodes of The Bird Bath

• Screwworms in US, Hill’s New CVMO, 701x Funding, More Mobile Moves · June 9, 2026 · 12 min
• Tractor Supply and VIP Petcare, Mission’s RE Sale, Mentorship Benefits, Just Food for Dogs · June 2, 2026 · 12 min
• Merck Ads vs. Elanco, Freshpet’s Whole Story, BI puts numbers to Vet Experience · May 26, 2026 · 12 min
• Elanco Settlement, Dogs’ Fear and Anxiety, Papaya Closure, Finally F1 · May 19, 2026 · 12 min
• TX VCPR Moves, New COOs, VetSnap’s Locker, Zoetis and IDEXX · May 12, 2026 · 13 min
• Trupanion Up, Homeward Out, College Changes, Colorado Win · May 5, 2026 · 13 min